Abstract Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by the
destruction of pancreatic β-cells, leading to insulin deficiency. Insulin replacement therapy is …

Diabetes mellitus is a metabolic disorder described by compromised insulin synthesis or
resistance to insulin inside the human body. Diabetes is a persistent metabolic condition …

Background and aims Mesenchymal stromal cells (MSCs) a potentially effective disease-
modulating therapy for diabetic nephropathy (DN) but their clinical translation has been …

This investigation aimed to establish the promising role of insulin-producing cells (IPCs)
growing from bone marrow-mesenchymal stem cells (BM-MSCs) in relieving hyperglycemia …

Aim In previous studies, the researchers observed an increase in insulin secretion in STZ‐
treated diabetic rats following treatment with the hydroalcoholic extract of Securigera …

Mitochondrial dysfunction plays an important role in the development of podocyte injury in
diabetic nephropathy (DN). Tunnelling nanotubes (TNTs) are long channels that connect …

Background Diabetes mellitus (DM) is a global epidemic with increasing incidences. DM is a
metabolic disease associated with chronic hyperglycemia. Aside from conventional …

Diabetes leads to testicular damage and infertility. Mesenchymal stem cells and their
secretory trophic factors have shown potential as regenerative therapies for diabetes and its …

Introduction: Stem cells can be used to treat diabetic mellitus and complications. ω3-
docosahexaenoic acid (DHA) derived lipid mediators are inflammation-resolving and …

Traditional antidiabetic treatments often carry the risk of beta-cell exhaustion, highlighting
the need for therapies that promote beta-cell regeneration. This study investigates the …